Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)
CUSIP: 19249H103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 153,624,096
- Total 13F shares
- 82,580,425
- Share change
- -46,665
- Total reported value
- $142,867,620
- Put/Call ratio
- 126%
- Price per share
- $1.73
- Number of holders
- 132
- Value change
- -$603,275
- Number of buys
- 68
- Number of sells
- 59
Quarterly Holders Quick Answers
What is CUSIP 19249H103?
CUSIP 19249H103 identifies CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 19249H103:
Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
7.3%
|
11,230,522
|
$26,840,947 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
6.8%
|
10,400,000
|
$24,856,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
10,079,554
|
$24,090,134 | — | 31 Mar 2024 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
4.8%
|
7,381,116
|
$17,640,867 | — | 31 Mar 2024 | |
| Kohlberg Kravis Roberts & Co. L.P. |
13F
|
Company |
2%
|
3,036,076
|
$7,256,224 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
2,742,627
|
$6,554,879 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
2,664,169
|
$6,367,366 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.6%
|
2,427,225
|
$5,801,067 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
2,203,694
|
$5,267,385 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
1.3%
|
2,065,351
|
$4,936,190 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
1,995,738
|
$4,769,814 | — | 31 Mar 2024 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
1.3%
|
1,928,464
|
$4,609,000 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,714,574
|
$4,097,832 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.95%
|
1,462,013
|
$3,494,211 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.82%
|
1,257,363
|
$3,005,098 | — | 31 Mar 2024 | |
| DISCIPLINED GROWTH INVESTORS INC /MN |
13F
|
Company |
0.82%
|
1,255,937
|
$3,001,689 | — | 31 Mar 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
0.69%
|
1,055,386
|
$2,522,373 | — | 31 Mar 2024 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.66%
|
1,016,455
|
$2,429,327 | — | 31 Mar 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.65%
|
1,000,000
|
$2,390,000 | — | 31 Mar 2024 | |
| CM Management, LLC |
13F
|
Company |
0.65%
|
1,000,000
|
$2,390,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
921,641
|
$2,202,721 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.59%
|
899,999
|
$2,151,000 | — | 31 Mar 2024 | |
| BIT Capital GmbH |
13F
|
Company |
0.56%
|
859,761
|
$2,054,829 | — | 31 Mar 2024 | |
| Clearline Capital LP |
13F
|
Company |
0.51%
|
784,449
|
$1,874,833 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.46%
|
700,000
|
$1,673,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.45%
|
689,126
|
$1,647,011 | — | 31 Mar 2024 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.36%
|
555,945
|
$1,328,709 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.35%
|
535,439
|
$1,279,699 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.34%
|
516,716
|
$1,234,951 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
391,363
|
$935,358 | — | 31 Mar 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.25%
|
387,700
|
$926,000 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.24%
|
361,562
|
$864,133 | — | 31 Mar 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.23%
|
356,978
|
$853,177 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.23%
|
346,157
|
$827,315 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.22%
|
341,202
|
$815,473 | — | 31 Mar 2024 | |
| Bridge City Capital, LLC |
13F
|
Company |
0.21%
|
315,384
|
$753,768 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
309,003
|
$738,517 | — | 31 Mar 2024 | |
| Birchview Capital, LP |
13F
|
Company |
0.18%
|
270,000
|
$645,300 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
227,079
|
$542,719 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.14%
|
217,641
|
$520,162 | — | 31 Mar 2024 | |
| Tyche Wealth Partners LLC |
13F
|
Company |
0.14%
|
215,902
|
$516,006 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.13%
|
207,100
|
$494,969 | — | 31 Mar 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.13%
|
196,625
|
$469,934 | — | 31 Mar 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
196,210
|
$468,942 | — | 31 Mar 2024 | |
| Pennant Investors, LP |
13F
|
Company |
0.11%
|
168,100
|
$401,759 | — | 31 Mar 2024 | |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.1%
|
155,036
|
$370,536 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
152,328
|
$364,000 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.1%
|
151,563
|
$362,236 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
146,500
|
$350,135 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.1%
|
146,231
|
$349,492 | — | 31 Mar 2024 |
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q2 2024
As of 30 Jun 2024,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,580,425 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Rubric Capital Management LP, Temasek Holdings (Private) Ltd, Kohlberg Kravis Roberts & Co. L.P., CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, BARCLAYS PLC, GOLDMAN SACHS GROUP INC, and STATE STREET CORP.
This page lists
132
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
134
Q2 2024 holders
132
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.